Patents by Inventor Ashish Pandey
Ashish Pandey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240401051Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.Type: ApplicationFiled: August 15, 2024Publication date: December 5, 2024Inventors: Ashish Pandey, Ariana Mostafa, Jacob Berger, Anurup Ganguli
-
Patent number: 12129468Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods provide signal boost upon detection of target nucleic acids of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 16° C. or less, without amplification of the target nucleic acids yet allowing for massive multiplexing, high accuracy and minimal non-specific signal generation.Type: GrantFiled: January 31, 2024Date of Patent: October 29, 2024Assignee: VedaBio, Inc.Inventors: Anurup Ganguli, Ashish Pandey, Ariana Mostafa, Jacob Berger
-
Patent number: 12104158Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.Type: GrantFiled: February 23, 2024Date of Patent: October 1, 2024Assignee: VedaBio, Inc.Inventors: Ashish Pandey, Ariana Mostafa, Jacob Berger, Anurup Ganguli
-
Patent number: 12091690Abstract: The present disclosure relates to variant engineered nucleic acid-guided nucleases that may be used in CRISPR-based cascade assay systems to detect one or more target nucleic acids in a sample. The variant nucleases comprise an activity such that double-stranded DNA substrates do not bind to or are not cleaved by variant LbCas12a nuclease, or bind to or are cleaved very slowly by the variant nuclease, however single-stranded DNA substrates can bind and are cleaved by the variant nuclease, and wherein the variant nuclease exhibits both cis- and trans-cleavage activity.Type: GrantFiled: January 2, 2024Date of Patent: September 17, 2024Assignee: VedaBio, Inc.Inventors: Andrew Garst, Anurup Ganguli, Ashish Pandey
-
Publication number: 20240228993Abstract: The present disclosure relates to variant engineered nucleic acid-guided nucleases that may be used in CRISPR-based cascade assay systems to detect one or more target nucleic acids in a sample.Type: ApplicationFiled: January 2, 2024Publication date: July 11, 2024Inventors: Andrew Garst, Anurup Ganguli, Ashish Pandey
-
Publication number: 20240218364Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods provide signal boost upon detection of target nucleic acids of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 16° ° C. or less, without amplification of the target nucleic acids yet allowing for massive multiplexing, high accuracy and minimal non-specific signal generation.Type: ApplicationFiled: January 31, 2024Publication date: July 4, 2024Inventors: Anurup Ganguli, Ashish Pandey, Ariana Mostafa, Jacob Berger
-
Publication number: 20240218428Abstract: The present disclosure describes compositions of matter comprising a ribonucleoprotein complex comprising a nucleic acid-guided nuclease and a guide RNA, and further comprising a blocking nucleic acid molecule represented by Formula IV, wherein Formula IV in the 5?-to-3? direction comprises: T-D-M-A-Lp-C; wherein T is 17-31 nucleotides in length; D is 0-15 nucleotides in length; M is 1-25 nucleotides in length; A is 0-15 nucleotides in length and comprises a sequence complementary to D; and L is 3-25 nucleotides in length; p is 0 or 1; C is 4-15 nucleotides in length and comprises a sequence complementary to T; and wherein the blocking nucleic acid molecule comprises a sequence complementary to a gRNA.Type: ApplicationFiled: February 25, 2024Publication date: July 4, 2024Inventors: Ashish Pandey, Anurup Ganguli, Ariana Mostafa, Jacob Berger
-
Publication number: 20240191234Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.Type: ApplicationFiled: February 23, 2024Publication date: June 13, 2024Inventors: Ashish Pandey, Ariana Mostafa, Jacob Berger, Anurup Ganguli
-
Patent number: 11987839Abstract: The present disclosure describes compositions of matter comprising a ribonucleoprotein complex comprising a nucleic acid-guided nuclease and a guide RNA, and further comprising a blocking nucleic acid molecule represented by Formula IV, wherein Formula IV in the 5?-to-3? direction comprises: T-D-M-A-Lp-C; wherein T is 17-31 nucleotides in length; D is 0-15 nucleotides in length; M is 1-25 nucleotides in length; A is 0-15 nucleotides in length and comprises a sequence complementary to D; and L is 3-25 nucleotides in length; p is 0 or 1; C is 4-15 nucleotides in length and comprises a sequence complementary to T; and wherein the blocking nucleic acid molecule comprises a sequence complementary to a gRNA.Type: GrantFiled: September 24, 2023Date of Patent: May 21, 2024Assignees: VedaBio, Inc., The Board of Trustees of The University of IllinoisInventors: Anurup Ganguli, Ariana Mostafa, Jacob Berger, Ashish Pandey
-
Patent number: 11970730Abstract: The present disclosure describes compositions of matter comprising a ribonucleoprotein complex comprising a nucleic acid-guided nuclease and a guide RNA, and further comprising and a blocking nucleic acid molecule represented by Formula III in the 5?-to-3? direction comprises: T-D-M-A-(B-L)J-C; wherein T is 17-135 nucleotides in length; D is 0-10 nucleotides in length; M is 1-25 nucleotides in length or is absent, wherein if M is absent then T-D and A-(B-L)J-C are separate nucleic acid strands; A is 0-15 nucleotides in length and comprises at least 50% sequence complementarity to D; B is 4-12 nucleotides in length and comprises at least 50% sequence complementarity to T; L is 3-25 nucleotides in length; J is an integer between 1 and 10; C is 4-15 nucleotides in length; and wherein the blocking nucleic acid molecule comprises a sequence complementary to a gRNA.Type: GrantFiled: June 10, 2023Date of Patent: April 30, 2024Assignee: VedaBio, Inc.Inventors: Anurup Ganguli, Ariana Mostafa, Jacob Berger, Ashish Pandey, Rashid Bashir
-
Patent number: 11954073Abstract: Disclosed are techniques for multi-protocol multi-site file replication, including a method comprising capturing, at a gateway device, IO operations performed on a filesystem, the filesystem having inode bits. The method may further comprise enqueuing the captured IO operations onto a plurality of queues, wherein each of the plurality of queues is associated with one of a plurality of target sites; and independently managing replication of the IO operations to the target sites using the inode bits.Type: GrantFiled: March 16, 2022Date of Patent: April 9, 2024Assignee: International Business Machines CorporationInventors: Venkateswara Rao Puvvada, Saket Kumar, Karrthik Kalaga Gopalakrishnan, Ashish Pandey
-
Patent number: 11946052Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.Type: GrantFiled: November 24, 2023Date of Patent: April 2, 2024Assignee: VedaBio, Inc.Inventors: Ariana Mostafa, Jacob Berger, Ashish Pandey, Anurup Ganguli
-
Publication number: 20240102014Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.Type: ApplicationFiled: November 24, 2023Publication date: March 28, 2024Inventors: Ariana Mostafa, Jacob Berger, Ashish Pandey, Anurup Ganguli
-
Publication number: 20240035028Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods provide signal boost upon detection of target nucleic acids of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 16° C. or less, without amplification of the target nucleic acids yet allowing for massive multiplexing, high accuracy and minimal non-specific signal generation.Type: ApplicationFiled: August 16, 2023Publication date: February 1, 2024Inventors: Anurup Ganguli, Ashish Pandey, Ariana Mostafa, Jacob Berger
-
Patent number: 11884921Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods provide signal boost upon detection of target nucleic acids of interest in less than one minute and in some instances instantaneously at ambient temperatures down to 16° C. or less, without amplification of the target nucleic acids yet allowing for massive multiplexing, high accuracy and minimal non-specific signal generation.Type: GrantFiled: December 9, 2022Date of Patent: January 30, 2024Assignee: VedaBio, Inc.Inventors: Anurup Ganguli, Ashish Pandey, Ariana Mostafa, Jacob Berger
-
Patent number: 11884922Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.Type: GrantFiled: June 10, 2023Date of Patent: January 30, 2024Assignee: VedaBio, Inc.Inventors: Ariana Mostafa, Jacob Berger, Ashish Pandey, Anurup Ganguli
-
Publication number: 20240026425Abstract: The present disclosure describes compositions of matter comprising a ribonucleoprotein complex comprising a nucleic acid-guided nuclease and a guide RNA, and further comprising and a blocking nucleic acid molecule represented by Formula IV, wherein Formula IV in the 5?-to-3? direction comprises: T-D-M-A-Lp-C; wherein T is 17-31 nucleotides in length; D is 0-15 nucleotides in length; M is 1-25 nucleotides in length; A is 0-15 nucleotides in length and comprises a sequence complementary to D; and L is 3-25 nucleotides in length; p is 0 or 1; C is 4-15 nucleotides in length and comprises a sequence complementary to T; and wherein the blocking nucleic acid molecule comprises a sequence complementary to a gRNA.Type: ApplicationFiled: September 24, 2023Publication date: January 25, 2024Inventors: Anurup Ganguli, Ariana Mostafa, Jacob Berger, Ashish Pandey, Rashid Bashir
-
Publication number: 20240018518Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.Type: ApplicationFiled: June 10, 2023Publication date: January 18, 2024Inventors: Ariana Mostafa, Jacob Berger, Ashish Pandey, Anurup Ganguli
-
Patent number: 11859182Abstract: The present disclosure relates to compositions of matter and assay methods used to detect one or more target nucleic acids of interest in a sample. The compositions and methods allow one to control reaction kinetics of the cascade assay by two orders of magnitude via molecular design of one of the reaction components; further, varying molecular design also allows for quantification of target nucleic acids of interest over a large range of concentrations or discriminating between extremely low copy numbers of target nucleic acids of interest.Type: GrantFiled: May 31, 2023Date of Patent: January 2, 2024Assignee: VedaBio, Inc.Inventors: Anurup Ganguli, Ariana Mostafa, Jacob Berger, Ashish Pandey
-
Publication number: 20230399682Abstract: The present disclosure describes compositions of matter comprising a ribonucleoprotein complex comprising a nucleic acid-guided nuclease and a guide RNA, and further comprising and a blocking nucleic acid molecule represented by Formula III in the 5?-to-3? direction comprises: T-D-M-A-(B-L)J-C; wherein T is 17-135 nucleotides in length; D is 0-10 nucleotides in length; M is 1-25 nucleotides in length or is absent, wherein if M is absent then T-D and A-(B-L)J-C are separate nucleic acid strands; A is 0-15 nucleotides in length and comprises at least 50% sequence complementarity to D; B is 4-12 nucleotides in length and comprises at least 50% sequence complementarity to T; L is 3-25 nucleotides in length; J is an integer between 1 and 10; C is 4-15 nucleotides in length; and wherein the blocking nucleic acid molecule comprises a sequence complementary to a gRNA.Type: ApplicationFiled: June 10, 2023Publication date: December 14, 2023Inventors: Anurup Ganguli, Ariana Mostafa, Jacob Berger, Ashish Pandey, Rashid Bashir